Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain.

Human psychopharmacology - 1 Jan 2000

Park Young-Min, Choi Jung-Eun, Kang Seung-Gul, Koo Seung-Hoi, Kim Leen, Geum Dongho, Lee Heon-Jeong

Abstract excerpt

BACKGROUND: Olanzapine is an atypical antipsychotic known to cause considerable weight gain. The cannabinoid type 1 receptor has been reported to be involved in energy balance control, appetite stimulation, and increases in body weight. METHODS: In the present study, we investigated three polymorphisms (rs1049353, rs806368, and rs4707436) in the cannabinoid type 1 receptor gene (CNR1) and weight gain in Korean...

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amplified Fragment Length Polymorphism Analysis
Share to Antipsychotic Agents
Share to Benzodiazepines
Share to Diagnostic and Statistical Manual of Mental Disorders
Share to Olanzapine
Share to Receptor, Cannabinoid, CB1
Share to Selective Serotonin Reuptake Inhibitors
Share to Weight Gain

Source

Identifiers

PMID: 21695734
DOI: 10.1002/hup.1210

Genes

CNR1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain.PMID 21695734Read ↗

Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients.Semantic proximity Read ↗

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia.Semantic proximity Read ↗

Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain.Semantic proximity Read ↗

Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain.Semantic proximity Read ↗

Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.Semantic proximity Read ↗

GIPR Gene Polymorphism and Weight Gain in Patients With Schizophrenia Treated With Olanzapine.Semantic proximity Read ↗

Association of the common MC4R rs17782313 polymorphism with antipsychotic-related weight gain.Semantic proximity Read ↗

Weight gain associated with the alpha2a-adrenergic receptor -1,291 C/G polymorphism and olanzapine treatment.Semantic proximity Read ↗

Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: an association study.Semantic proximity Read ↗

Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone.Semantic proximity Read ↗

Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed.Semantic proximity Read ↗

Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.